HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Ma Selected Research

ubiquitin C-terminal 7-amido-4-methylcoumarin

1/2019Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Ma Research Topics

Disease

129Neoplasms (Cancer)
07/2022 - 09/2006
109Breast Neoplasms (Breast Cancer)
07/2022 - 01/2010
39Triple Negative Breast Neoplasms
01/2022 - 02/2010
32Neoplasm Metastasis (Metastasis)
02/2022 - 05/2011
20Inflammation (Inflammations)
05/2022 - 07/2002
18Pain (Aches)
01/2022 - 11/2002
17Stomach Neoplasms (Stomach Cancer)
04/2021 - 11/2013
14Cognitive Dysfunction
10/2022 - 01/2011
14Carcinogenesis
12/2021 - 09/2006
11Gallbladder Neoplasms (Gallbladder Cancer)
02/2022 - 05/2015
11Neuralgia (Stump Neuralgia)
03/2019 - 07/2004
10Alzheimer Disease (Alzheimer's Disease)
04/2022 - 01/2011
10Hyperalgesia
01/2022 - 08/2002
10Hypersensitivity (Allergy)
01/2021 - 07/2012
9Disease Progression
10/2021 - 01/2010
7Infections
11/2021 - 01/2017
6Hypertension (High Blood Pressure)
03/2021 - 09/2008
6Lymphatic Metastasis
01/2021 - 03/2013
5Hemorrhage
04/2022 - 12/2006
5Neutropenia
01/2022 - 10/2015
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2015
5Carcinoma (Carcinomatosis)
03/2021 - 01/2017
5Type 2 Diabetes Mellitus (MODY)
09/2019 - 02/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 10/2009
5Ganglion Cysts (Ganglion)
02/2008 - 03/2005
4Lung Neoplasms (Lung Cancer)
05/2022 - 01/2017
4Diarrhea
01/2022 - 09/2014
4Bacterial Infections (Bacterial Infection)
01/2022 - 01/2017
4Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 01/2016
4Hand-Foot Syndrome
03/2021 - 10/2019
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2019
4Circulating Neoplastic Cells
01/2021 - 01/2015
3Cardiotoxicity
06/2022 - 12/2014

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2005
27Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2013
25MicroRNAs (MicroRNA)IBA
05/2022 - 01/2013
24Hormones (Hormone)IBA
07/2022 - 01/2011
19Pharmaceutical PreparationsIBA
01/2022 - 05/2008
18AnthracyclinesIBA
06/2022 - 01/2010
16human ERBB2 proteinIBA
01/2022 - 09/2012
12Indicators and Reagents (Reagents)IBA
07/2022 - 02/2008
12Taxoids (Taxanes)IBA
03/2021 - 01/2010
12Capecitabine (Xeloda)FDA Link
01/2021 - 01/2010
11Folic Acid (Vitamin M)FDA LinkGeneric
10/2022 - 01/2015
11Phenobarbital (Luminal)FDA Link
07/2022 - 12/2013
11Estrogen ReceptorsIBA
07/2022 - 02/2010
11Messenger RNA (mRNA)IBA
01/2022 - 07/2004
11Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 02/2010
10Long Noncoding RNAIBA
02/2022 - 10/2016
10Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2012
10Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 06/2012
10Trastuzumab (Herceptin)FDA Link
07/2021 - 07/2013
10DNA (Deoxyribonucleic Acid)IBA
02/2021 - 01/2017
9RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
9Macrophage Migration-Inhibitory FactorsIBA
01/2022 - 01/2015
8ErbB Receptors (EGF Receptor)IBA
07/2022 - 05/2017
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 06/2012
8PlatinumIBA
01/2022 - 10/2014
8Circulating Tumor DNAIBA
01/2022 - 01/2017
7Carboplatin (JM8)FDA LinkGeneric
01/2022 - 06/2012
7EnzymesIBA
11/2021 - 01/2016
7Biological ProductsIBA
03/2021 - 06/2009
7Peptides (Polypeptides)IBA
12/2020 - 07/2004
6CytokinesIBA
04/2022 - 06/2009
6HMGB1 Protein (HMG1)IBA
01/2022 - 01/2016
6Vinorelbine (Navelbine)FDA LinkGeneric
07/2021 - 01/2010
6Analgesics (Analgesic Drugs)IBA
04/2021 - 07/2004
6Glucose (Dextrose)FDA LinkGeneric
04/2021 - 03/2009
6pyrotinibIBA
01/2021 - 09/2017
6AntigensIBA
01/2021 - 07/2015
6Cisplatin (Platino)FDA LinkGeneric
12/2018 - 07/2012
5HomocysteineIBA
01/2022 - 01/2015
5Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2014
5Lapatinib (GW572016)FDA Link
01/2021 - 08/2012
5Aromatase InhibitorsIBA
01/2020 - 01/2011
5Biosimilar PharmaceuticalsIBA
01/2020 - 01/2019
5LipidsIBA
01/2020 - 01/2011
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 04/2017
4Docetaxel (Taxotere)FDA Link
01/2022 - 06/2012
4Epidermal Growth Factor (EGF)IBA
01/2022 - 01/2018
4Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 02/2013
4CateninsIBA
09/2021 - 02/2014
4apatinibIBA
05/2021 - 06/2019
4Carrier Proteins (Binding Protein)IBA
02/2021 - 09/2006
4protease-activated receptor 4IBA
01/2019 - 01/2016
4Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2019 - 01/2015
4LigandsIBA
01/2019 - 05/2005
4taxaneIBA
01/2018 - 10/2015
3ApolipoproteinsIBA
10/2022 - 01/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2017

Therapy/Procedure

61Therapeutics
07/2022 - 05/2009
47Drug Therapy (Chemotherapy)
06/2022 - 05/2011
13Neoadjuvant Therapy
01/2022 - 09/2012
12Adjuvant Chemotherapy
06/2022 - 06/2012
6Aftercare (After-Treatment)
01/2022 - 11/2014
5Radiotherapy
01/2022 - 11/2017
5Gastrectomy
04/2021 - 11/2013
4Analgesia
08/2012 - 10/2003
4Electroacupuncture
03/2006 - 07/2004
3Palliative Care (Palliative Therapy)
02/2022 - 01/2015